⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

RXRX

Recursion Pharmaceuticals, Inc.

Healthcare · Biotechnology

3.70USD

+0.1200 (+3.35%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on RXRX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 3.70
P/E—
Dvd Ind Yld0.0%
P/B2.17
P/S36.2
Curr EV/T12M EBITDA-3.2
Mkt Cap (USD)2.0B
Curr EV (USD)1.5B
2)

Per Share Data

EPS T12M-1.07
DPS—
Bk Val Per Sh1.71
Rev/Sh0.10
Cash/Sh1.02
Curr Shares Out535.3M
FCF/Sh-0.66
3)

Cash Flow Analysis

P/CF-5.7
Curr P/FCF-5.6
CF/NI0.7
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-638.9%
Eff Interest Rate204.8%
4)

Growth Potential

Dil EPS 1Y Gr14.8%
Cap 1Y Gr9.3%
BPS 1Y Gr-33.0%
R&D To Sales719.2%
Retention Rate—
Rev 1Y Gr26.9%
FCF 1Y Gr-1.5%
Assets 1Y Gr1.8%
5)

Profitability

EBITDA-0.5B
EBIT-0.5B
Operating Margin-991.7%
Pretax Margin-954.3%
Net Margin-945.9%
ROA-41.3%
ROE-56.6%
ROC-54.9%
Asset Turnover0.04
6)

Structure

Current Ratio5.03
Quick Ratio4.67
Debt/Assets5.5%
Debt/Com Eq7.3%
Net Debt/EBITDA1.03
Tot Debt/Capital6.8%
Gross Margin3.5%
EBIT/Int Exp-367.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.